News
Early human data in a statement by Eolo Pharma shows it can burn fat even at rest, without appetite suppression or serious ...
Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...
Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival ...
Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...
Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside ...
SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.
Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body shapes and sizes.
1d
Pharmaceutical Technology on MSNEli Lilly’s Mounjaro shows cardiovascular gains, but analysts underwhelmed
Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
Research increasingly suggests that nutrient sequencing—eating macronutrients like protein and fiber in a particular ...
If you’re aiming to build muscle, shed some pounds, or just need assistance in reaching your daily protein targets, protein ...
As rates of childhood obesity rise, clinicians call for increased data collection to support insurance coverage and safe use of glucagon-like peptide 1 (GLP-1) medications in children under 12 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results